Skip navigation

DSpace JSPUI

DSpace preserves and enables easy and open access to all types of digital content including text, images, moving images, mpegs and data sets

Learn More
DSpace logo
English
中文
  • Browse
    • Communities
      & Collections
    • Publication Year
    • Author
    • Title
    • Subject
    • Advisor
  • Search TDR
  • Rights Q&A
    • My Page
    • Receive email
      updates
    • Edit Profile
  1. NTU Theses and Dissertations Repository
  2. 醫學院
  3. 醫學檢驗暨生物技術學系
Please use this identifier to cite or link to this item: http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/64656
Full metadata record
???org.dspace.app.webui.jsptag.ItemTag.dcfield???ValueLanguage
dc.contributor.advisor張淑媛
dc.contributor.authorHuei-Ling Huangen
dc.contributor.author黃惠玲zh_TW
dc.date.accessioned2021-06-16T22:56:59Z-
dc.date.available2022-08-09
dc.date.copyright2012-09-18
dc.date.issued2012
dc.date.submitted2012-08-09
dc.identifier.citation1. Alexander, L., M. J. Aquino-DeJesus, M. Chan, and W. A. Andiman. 2002. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by a two-amino-acid insertion in HIV-1 Vif from a nonprogressing mother and child. J Virol 76:10533-9.
2. Alexander, L., E. Weiskopf, T. C. Greenough, N. C. Gaddis, M. R. Auerbach, M. H. Malim, S. J. O'Brien, B. D. Walker, J. L. Sullivan, and R. C. Desrosiers. 2000. Unusual polymorphisms in human immunodeficiency virus type 1 associated with nonprogressive infection. J Virol 74:4361-76.
3. Butticaz, C., O. Michielin, J. Wyniger, A. Telenti, and S. Rothenberger. 2007. Silencing of both beta-TrCP1 and HOS (beta-TrCP2) is required to suppress human immunodeficiency virus type 1 Vpu-mediated CD4 down-modulation. J Virol 81:1502-5.
4. Caly, L., N. K. Saksena, S. C. Piller, and D. A. Jans. 2008. Impaired nuclear import and viral incorporation of Vpr derived from a HIV long-term non-progressor. Retrovirology 5:67.
5. Casartelli, N., G. Di Matteo, M. Potesta, P. Rossi, and M. Doria. 2003. CD4 and major histocompatibility complex class I downregulation by the human immunodeficiency virus type 1 nef protein in pediatric AIDS progression. J Virol 77:11536-45.
6. Chang, S. Y., W. H. Sheng, C. N. Lee, H. Y. Sun, C. L. Kao, S. F. Chang, W. C. Liu, J. Y. Yang, W. W. Wong, C. C. Hung, and S. C. Chang. 2006. Molecular epidemiology of HIV type 1 subtypes in Taiwan: outbreak of HIV type 1 CRF07_BC infection in intravenous drug users. AIDS Res Hum Retroviruses 22:1055-66.
7. Chen, M., R. T. Elder, M. Yu, M. G. O'Gorman, L. Selig, R. Benarous, A. Yamamoto, and Y. Zhao. 1999. Mutational analysis of Vpr-induced G2 arrest, nuclear localization, and cell death in fission yeast. J Virol 73:3236-45.
8. Chen, Y. M., K. L. Huang, I. Jen, S. C. Chen, Y. C. Liu, Y. C. Chuang, J. C. Wong, J. J. Tsai, and Y. C. Lan. 2001. Temporal trends and molecular epidemiology of HIV-1 infection in Taiwan from 1988 to 1998. J Acquir Immune Defic Syndr 26:274-82.
9. Chen, Y. M., Y. C. Lan, S. F. Lai, J. Y. Yang, S. F. Tsai, and S. H. Kuo. 2006. HIV-1 CRF07_BC infections, injecting drug users, Taiwan. Emerg Infect Dis 12:703-5.
10. Cohen, O. J., and A. S. Fauci. 2001. Pathogenesis and Medical Aspects of HIV Infection, p. 2043. In D. M. Knipe and P. M. Howley (ed.), Fields Virology, vol. 2. Lippincott Williams&Wilkins, Philadelphia.
11. Connor, R. I., B. K. Chen, S. Choe, and N. R. Landau. 1995. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 206:935-44.
12. Deacon, N. J., A. Tsykin, A. Solomon, K. Smith, M. Ludford-Menting, D. J. Hooker, D. A. McPhee, A. L. Greenway, A. Ellett, C. Chatfield, V. A. Lawson, S. Crowe, A. Maerz, S. Sonza, J. Learmont, J. S. Sullivan, A. Cunningham, D. Dwyer, D. Dowton, and J. Mills. 1995. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 270:988-91.
13. Dean, M., M. Carrington, C. Winkler, G. A. Huttley, M. W. Smith, R. Allikmets, J. J. Goedert, S. P. Buchbinder, E. Vittinghoff, E. Gomperts, S. Donfield, D. Vlahov, R. Kaslow, A. Saah, C. Rinaldo, R. Detels, and S. J. O'Brien. 1996. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 273:1856-62.
14. Freed, E. O., and M. A. Martin. 2001. HIVs and Their Replication, p. 1971. In D. M. Knipe and P. M. Howley (ed.), Fields Virology, vol. 2. Lippincott Williams&Wilkins, Philadelphia.
15. Gupta, S. B., L. P. Jacobson, J. B. Margolick, C. R. Rinaldo, J. P. Phair, B. D. Jamieson, D. V. Mehrotra, M. N. Robertson, and W. L. Straus. 2007. Estimating the benefit of an HIV-1 vaccine that reduces viral load set point. J Infect Dis 195:546-50.
16. Harris, R. S., K. N. Bishop, A. M. Sheehy, H. M. Craig, S. K. Petersen-Mahrt, I. N. Watt, M. S. Neuberger, and M. H. Malim. 2003. DNA deamination mediates innate immunity to retroviral infection. Cell 113:803-9.
17. Hassaine, G., I. Agostini, D. Candotti, G. Bessou, M. Caballero, H. Agut, B. Autran, Y. Barthalay, and R. Vigne. 2000. Characterization of human immunodeficiency virus type 1 vif gene in long-term asymptomatic individuals. Virology 276:169-80.
18. He, J., S. Choe, R. Walker, P. Di Marzio, D. O. Morgan, and N. R. Landau. 1995. Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J Virol 69:6705-11.
19. Heinzinger, N. K., M. I. Bukinsky, S. A. Haggerty, A. M. Ragland, V. Kewalramani, M. A. Lee, H. E. Gendelman, L. Ratner, M. Stevenson, and M. Emerman. 1994. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc Natl Acad Sci U S A 91:7311-5.
20. Hogan, T. H., M. R. Nonnemacher, F. C. Krebs, A. Henderson, and B. Wigdahl. 2003. HIV-1 Vpr binding to HIV-1 LTR C/EBP cis-acting elements and adjacent regions is sequence-specific. Biomed Pharmacother 57:41-8.
21. Iwabu, Y., H. Fujita, M. Kinomoto, K. Kaneko, Y. Ishizaka, Y. Tanaka, T. Sata, and K. Tokunaga. 2009. HIV-1 accessory protein Vpu internalizes cell-surface BST-2/tetherin through transmembrane interactions leading to lysosomes. J Biol Chem 284:35060-72.
22. Jeang, K. T., H. Xiao, and E. A. Rich. 1999. Multifaceted activities of the HIV-1 transactivator of transcription, Tat. J Biol Chem 274:28837-40.
23. Jin, X., H. Wu, and H. Smith. 2007. APOBEC3G levels predict rates of progression to AIDS. Retrovirology 4:20.
24. Kim, Y. K., C. F. Bourgeois, C. Isel, M. J. Churcher, and J. Karn. 2002. Phosphorylation of the RNA polymerase II carboxyl-terminal domain by CDK9 is directly responsible for human immunodeficiency virus type 1 Tat-activated transcriptional elongation. Mol Cell Biol 22:4622-37.
25. Kirchhoff, F., T. C. Greenough, D. B. Brettler, J. L. Sullivan, and R. C. Desrosiers. 1995. Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N Engl J Med 332:228-32.
26. Klein, M. R., S. H. van der Burg, E. Hovenkamp, A. M. Holwerda, J. W. Drijfhout, C. J. Melief, and F. Miedema. 1998. Characterization of HLA-B57-restricted human immunodeficiency virus type 1 Gag- and RT-specific cytotoxic T lymphocyte responses. J Gen Virol 79 ( Pt 9):2191-201.
27. Kobayashi, M., A. Takaori-Kondo, Y. Miyauchi, K. Iwai, and T. Uchiyama. 2005. Ubiquitination of APOBEC3G by an HIV-1 Vif-Cullin5-Elongin B-Elongin C complex is essential for Vif function. J Biol Chem 280:18573-8.
28. Krausslich, H. G. 1991. Human immunodeficiency virus proteinase dimer as component of the viral polyprotein prevents particle assembly and viral infectivity. Proc Natl Acad Sci U S A 88:3213-7.
29. Lapatto, R., T. Blundell, A. Hemmings, J. Overington, A. Wilderspin, S. Wood, J. R. Merson, P. J. Whittle, D. E. Danley, K. F. Geoghegan, and et al. 1989. X-ray analysis of HIV-1 proteinase at 2.7 A resolution confirms structural homology among retroviral enzymes. Nature 342:299-302.
30. Lee, C. N., W. K. Wang, W. S. Fan, S. J. Twu, S. C. Chen, M. C. Sheng, and M. Y. Chen. 2000. Determination of human immunodeficiency virus type 1 subtypes in Taiwan by vpu gene analysis. J Clin Microbiol 38:2468-74.
31. Levy, J. A. 2009. HIV pathogenesis: 25 years of progress and persistent challenges. AIDS 23:147-60.
32. Lin, H. H., Y. L. Shih, Y. C. Liu, S. S. Lee, C. K. Huang, Y. L. Chen, C. Chin, C. H. Lai, H. C. Tsai, Y. C. Guo, and L. Zhang. 2006. An epidemic of HIV type I CRF07_BC infection among injection drug users in Taiwan. J Acquir Immune Defic Syndr 42:248-55.
33. Louis, J. M., G. M. Clore, and A. M. Gronenborn. 1999. Autoprocessing of HIV-1 protease is tightly coupled to protein folding. Nat Struct Biol 6:868-75.
34. Louis, J. M., E. M. Wondrak, A. R. Kimmel, P. T. Wingfield, and N. T. Nashed. 1999. Proteolytic processing of HIV-1 protease precursor, kinetics and mechanism. J Biol Chem 274:23437-42.
35. Ludwig, C., A. Leiherer, and R. Wagner. 2008. Importance of protease cleavage sites within and flanking human immunodeficiency virus type 1 transframe protein p6* for spatiotemporal regulation of protease activation. J Virol 82:4573-84.
36. Lum, J. J., O. J. Cohen, Z. Nie, J. G. Weaver, T. S. Gomez, X. J. Yao, D. Lynch, A. A. Pilon, N. Hawley, J. E. Kim, Z. Chen, M. Montpetit, J. Sanchez-Dardon, E. A. Cohen, and A. D. Badley. 2003. Vpr R77Q is associated with long-term nonprogressive HIV infection and impaired induction of apoptosis. J Clin Invest 111:1547-54.
37. Macreadie, I. G., L. A. Castelli, D. R. Hewish, A. Kirkpatrick, A. C. Ward, and A. A. Azad. 1995. A domain of human immunodeficiency virus type 1 Vpr containing repeated H(S/F)RIG amino acid motifs causes cell growth arrest and structural defects. Proc Natl Acad Sci U S A 92:2770-4.
38. Masciotra, S., S. M. Owen, D. Rudolph, C. Yang, B. Wang, N. Saksena, T. Spira, S. Dhawan, and R. B. Lal. 2002. Temporal relationship between V1V2 variation, macrophage replication, and coreceptor adaptation during HIV-1 disease progression. AIDS 16:1887-98.
39. McClutchan, F. E., J. K. Carr, D. Murphy, S. Piyasirisilp, F. Gao, B. Hahn, X. F. Yu, C. Beyrer, and D. L. Birx. 2002. Precise mapping of recombination breakpoints suggests a common parent of two BC recombinant HIV type 1 strains circulating in China. AIDS Res Hum Retroviruses 18:1135-40.
40. McNeil, A. J., P. L. Yap, S. M. Gore, R. P. Brettle, M. McColl, R. Wyld, S. Davidson, R. Weightman, A. M. Richardson, and J. R. Robertson. 1996. Association of HLA types A1-B8-DR3 and B27 with rapid and slow progression of HIV disease. QJM 89:177-85.
41. Mehle, A., B. Strack, P. Ancuta, C. Zhang, M. McPike, and D. Gabuzda. 2004. Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway. J Biol Chem 279:7792-8.
42. Meng, Z., X. He, H. Xing, R. Xin, J. Sun, F. Yi, L. Ma, and Y. Shao. 2008. Construction and characterization of an infectious molecular clone of HIV type 1 CRF07_BC. AIDS Res Hum Retroviruses 24:259-64.
43. Michael, N. L., G. Chang, L. A. d'Arcy, C. J. Tseng, D. L. Birx, and H. W. Sheppard. 1995. Functional characterization of human immunodeficiency virus type 1 nef genes in patients with divergent rates of disease progression. J Virol 69:6758-69.
44. Migueles, S. A., M. S. Sabbaghian, W. L. Shupert, M. P. Bettinotti, F. M. Marincola, L. Martino, C. W. Hallahan, S. M. Selig, D. Schwartz, J. Sullivan, and M. Connors. 2000. HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc Natl Acad Sci U S A 97:2709-14.
45. Mologni, D., P. Citterio, B. Menzaghi, B. Zanone Poma, C. Riva, V. Broggini, A. Sinicco, L. Milazzo, F. Adorni, S. Rusconi, M. Galli, and A. Riva. 2006. Vpr and HIV-1 disease progression: R77Q mutation is associated with long-term control of HIV-1 infection in different groups of patients. AIDS 20:567-74.
46. Navia, M. A., P. M. Fitzgerald, B. M. McKeever, C. T. Leu, J. C. Heimbach, W. K. Herber, I. S. Sigal, P. L. Darke, and J. P. Springer. 1989. Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1. Nature 337:615-20.
47. Oelrichs, R., A. Tsykin, D. Rhodes, A. Solomon, A. Ellett, D. McPhee, and N. Deacon. 1998. Genomic sequence of HIV type 1 from four members of the Sydney Blood Bank Cohort of long-term nonprogressors. AIDS Res Hum Retroviruses 14:811-4.
48. Pantaleo, G., and A. S. Fauci. 1996. Immunopathogenesis of HIV infection. Annu Rev Microbiol 50:825-54.
49. Pantaleo, G., C. Graziosi, and A. S. Fauci. 1993. New concepts in the immunopathogenesis of human immunodeficiency virus infection. N Engl J Med 328:327-35.
50. Papathanasopoulos, M. A., T. Patience, T. M. Meyers, F. E. McCutchan, and L. Morris. 2003. Full-length genome characterization of HIV type 1 subtype C isolates from two slow-progressing perinatally infected siblings in South Africa. AIDS Res Hum Retroviruses 19:1033-7.
51. Pettit, S. C., N. Sheng, R. Tritch, S. Erickson-Viitanen, and R. Swanstrom. 1998. The regulation of sequential processing of HIV-1 Gag by the viral protease. Adv Exp Med Biol 436:15-25.
52. Piacentini, L., M. Biasin, C. Fenizia, and M. Clerici. 2009. Genetic correlates of protection against HIV infection: the ally within. J Intern Med 265:110-24.
53. Piyasirisilp, S., F. E. McCutchan, J. K. Carr, E. Sanders-Buell, W. Liu, J. Chen, R. Wagner, H. Wolf, Y. Shao, S. Lai, C. Beyrer, and X. F. Yu. 2000. A recent outbreak of human immunodeficiency virus type 1 infection in southern China was initiated by two highly homogeneous, geographically separated strains, circulating recombinant form AE and a novel BC recombinant. J Virol 74:11286-95.
54. Poropatich, K., and D. J. Sullivan, Jr. 2011. Human immunodeficiency virus type 1 long-term non-progressors: the viral, genetic and immunological basis for disease non-progression. J Gen Virol 92:247-68.
55. Quinones-Mateu, M. E., A. Mas, T. Lain de Lera, V. Soriano, J. Alcami, M. M. Lederman, and E. Domingo. 1998. LTR and tat variability of HIV-1 isolates from patients with divergent rates of disease progression. Virus Res 57:11-20.
56. Rhodes, D. I., L. Ashton, A. Solomon, A. Carr, D. Cooper, J. Kaldor, and N. Deacon. 2000. Characterization of three nef-defective human immunodeficiency virus type 1 strains associated with long-term nonprogression. Australian Long-Term Nonprogressor Study Group. J Virol 74:10581-8.
57. Richardson, M. W., J. Mirchandani, J. Duong, S. Grimaldo, V. Kocieda, H. Hendel, K. Khalili, J. F. Zagury, and J. Rappaport. 2003. Antibodies to Tat and Vpr in the GRIV cohort: differential association with maintenance of long-term non-progression status in HIV-1 infection. Biomed Pharmacother 57:4-14.
58. Robertson, D. L., J. P. Anderson, J. A. Bradac, J. K. Carr, B. Foley, R. K. Funkhouser, F. Gao, B. H. Hahn, M. L. Kalish, C. Kuiken, G. H. Learn, T. Leitner, F. McCutchan, S. Osmanov, M. Peeters, D. Pieniazek, M. Salminen, P. M. Sharp, S. Wolinsky, and B. Korber. 2000. HIV-1 nomenclature proposal. Science 288:55-6.
59. Robertson, D. L., J. P. Anderson, J. A. Bradac, J. K. Carr, B. Foley, R. K. Funkhouser, F. Gao, B. H. Hahn, M. L. Kalish, C. Kuiken, G. H. Learn, T. Leitner, F. McCutchan, S. Osmanov, M. Peeters, D. Pieniazek, M. Salminen, P. M. Sharp, S. Wolinsky, and B. Korber. 1999. The Human Retroviruses and AIDS 1999 Compendium, vol. 1999. Los Alamos National Laboratory, Los Alamos.
60. Salvi, R., A. R. Garbuglia, A. Di Caro, S. Pulciani, F. Montella, and A. Benedetto. 1998. Grossly defective nef gene sequences in a human immunodeficiency virus type 1-seropositive long-term nonprogressor. J Virol 72:3646-57.
61. Samson, M., F. Libert, B. J. Doranz, J. Rucker, C. Liesnard, C. M. Farber, S. Saragosti, C. Lapoumeroulie, J. Cognaux, C. Forceille, G. Muyldermans, C. Verhofstede, G. Burtonboy, M. Georges, T. Imai, S. Rana, Y. Yi, R. J. Smyth, R. G. Collman, R. W. Doms, G. Vassart, and M. Parmentier. 1996. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382:722-5.
62. Sherman, M. P., C. M. de Noronha, M. I. Heusch, S. Greene, and W. C. Greene. 2001. Nucleocytoplasmic shuttling by human immunodeficiency virus type 1 Vpr. J Virol 75:1522-32.
63. Su, L., M. Graf, Y. Zhang, H. von Briesen, H. Xing, J. Kostler, H. Melzl, H. Wolf, Y. Shao, and R. Wagner. 2000. Characterization of a virtually full-length human immunodeficiency virus type 1 genome of a prevalent intersubtype (C/B') recombinant strain in China. J Virol 74:11367-76.
64. Tessmer, U., and H. G. Krausslich. 1998. Cleavage of human immunodeficiency virus type 1 proteinase from the N-terminally adjacent p6* protein is essential for efficient Gag polyprotein processing and viral infectivity. J Virol 72:3459-63.
65. Varthakavi, V., R. M. Smith, S. P. Bour, K. Strebel, and P. Spearman. 2003. Viral protein U counteracts a human host cell restriction that inhibits HIV-1 particle production. Proc Natl Acad Sci U S A 100:15154-9.
66. Vazquez-Perez, J. A., C. E. Ormsby, R. Hernandez-Juan, K. J. Torres, and G. Reyes-Teran. 2009. APOBEC3G mRNA expression in exposed seronegative and early stage HIV infected individuals decreases with removal of exposure and with disease progression. Retrovirology 6:23.
67. Visco-Comandini, U., Z. Yun, A. Vahlne, and A. Sonnerborg. 1999. No association of HIV type 1 long terminal repeat sequence pattern with long-term nonprogression and in vivo viral replication levels in European subjects. AIDS Res Hum Retroviruses 15:609-17.
68. Wang, B., Y. C. Ge, P. Palasanthiran, S. H. Xiang, J. Ziegler, D. E. Dwyer, C. Randle, D. Dowton, A. Cunningham, and N. K. Saksena. 1996. Gene defects clustered at the C-terminus of the vpr gene of HIV-1 in long-term nonprogressing mother and child pair: in vivo evolution of vpr quasispecies in blood and plasma. Virology 223:224-32.
69. Wang, B., T. J. Spira, S. Owen, R. B. Lal, and N. K. Saksena. 2000. HIV-1 strains from a cohort of American subjects reveal the presence of a V2 region extension unique to slow progressors and non-progressors. AIDS 14:213-23.
70. Weeks, K. M., C. Ampe, S. C. Schultz, T. A. Steitz, and D. M. Crothers. 1990. Fragments of the HIV-1 Tat protein specifically bind TAR RNA. Science 249:1281-5.
71. Westby, M., F. Manca, and A. G. Dalgleish. 1996. The role of host immune responses in determining the outcome of HIV infection. Immunol Today 17:120-6.
72. Yu, X. F., J. Chen, Y. Shao, C. Beyrer, B. Liu, Z. Wang, W. Liu, J. Yang, S. Liang, R. P. Viscidi, J. Gu, G. Gurri-Glass, and S. Lai. 1999. Emerging HIV infections with distinct subtypes of HIV-1 infection among injection drug users from geographically separate locations in Guangxi Province, China. J Acquir Immune Defic Syndr 22:180-8.
73. Zhang, H., B. Yang, R. J. Pomerantz, C. Zhang, S. C. Arunachalam, and L. Gao. 2003. The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 424:94-8.
74. Zhang, Q., X. Zhang, H. Wu, D. Seto, H. J. Zhang, Z. Chen, C. Wan, and B. J. Zheng. 2012. Parental LTRs are important in a construct of a stable and efficient replication-competent infectious molecular clone of HIV-1 CRF08_BC. PLoS One 7:e31233.
75. Zhao, Y., M. Chen, B. Wang, J. Yang, R. T. Elder, X. Q. Song, M. Yu, and N. K. Saksena. 2002. Functional conservation of HIV-1 Vpr and variability in a mother-child pair of long-term non-progressors. Virus Res 89:103-21.
76. Zhefeng, M., H. Huiliang, Q. Chao, S. Jun, L. Jianxin, Z. Xiaoyan, and X. Jianqing. 2011. Transmission of new CRF07_BC strains with 7 amino acid deletion in Gag p6. Virol J 8:60.
77. Zheng, X., C. Tian, K. H. Choi, J. Zhang, H. Cheng, X. Yang, D. Li, J. Lin, S. Qu, X. Sun, and et al. 1994. Injecting drug use and HIV infection in southwest China. Aids 8:1141-7.
dc.identifier.urihttp://tdr.lib.ntu.edu.tw/jspui/handle/123456789/64656-
dc.description.abstract影響人類免疫缺乏病毒(HIV)疾病進程快慢的主要因素可分為病毒因子和宿主的遺傳因子。藉由了解疾病進程較為緩慢之感染者體內病毒的特徵,將有助於發展預防HIV感染及臨床治療的策略。在2004年之前,台灣HIV的傳播主要是經由性行為接觸;約70% HIV感染者經由同性間性行為感染B亞型病毒,其餘則經由異性間性行為感染CRF01_AE亞型病毒。然而,在2004年,靜脈藥癮族群爆發CRF07_BC亞型病毒感染。根據臨床資料,我們發現,相較於B亞型病毒感染者,這些CRF07_BC感染者在接受高效能抗反轉錄病毒療法(HAART)前,其體內HIV病毒量較低、CD4+血球數目較高。因此,本研究的目的為人類免疫缺乏病毒CRF07_BC重組亞型病毒株之功能性探討。
我們構築出CRF07_BC 病毒株全長基因體的molecular clone (pCRF07_BC)以進行此重組亞型病毒之功能性探討。比較B亞型與CRF07_BC重組亞型病毒株之全長基因體序列,分析CRF07_BC重組亞型之病毒基因是否帶有缺失性突變,並利用功能性試驗(functional assay)探討病毒基因序列變異對病毒表現型的影響。最後,利用CRF07_BC molecular clone製造出野生型或突變型CRF07_BC病毒,以確認上述實驗結果。
經由核酸序列分析,發現相較於B亞型HXB2病毒株之LTR序列,pCRF07_BC有2個核酸刪除性突變分別發生於NF-KB ⅰ及SP-1 I轉錄因子結合位。除此之外,相較於HXB2之LTR序列,pCRF07_BC在核酸位置340-349之間,共發生4個核酸插入性突變及2個核酸替換性突變,因而產生第三個NF-KB轉錄因子結合位。另外,比較pCRF07_BC與HIV資料庫中B、C、CRF07_BC亞型參考株之全長基因體序列,分析CRF07_BC亞型之病毒基因是否帶有缺失性突變,導致蛋白質功能缺失。發現CRF07_BC之p6基因片段發生21個核酸刪除性突變,造成CRF07_BC之p6gag發生30PIDKELY36刪除性突變;p6pol蛋白質發生38ADRQGTV44刪除性突變。也發現CRF07_BC在Vif蛋白質Cul5 motif與BC box motif之間有天門冬醯酸(Asparagine)插入性突變;在Vpr蛋白質NLS motif有A89T突變;在Nef蛋白質N端蛋白質豆蔻醯化(myristoylation)功能區段內有G3A突變。
之後分析臨床病毒株的p6基因片段,我們發現所有的32個CRF07_BC病毒株之p6gag及 p6pol蛋白質均發生如上述之7個胺基酸刪除性突變,發生刪除性突變的比例為100% (32/32)。由於p6刪除性突變發生的位點位於病毒蛋白酶切割位點的附近,可能影響蛋白酶切割polyprotein的效率,所以我們利用西方墨點法比較感染細胞內病毒蛋白質成份組成,來分析CRF07_BC病毒的蛋白質切割效率,發現相較於B亞型臨床病毒株,CRF07_BC臨床病毒株之p24gag/Pr55gag的比值較低,顯示CRF07_BC亞型病毒蛋白酶切割Gag polyprotein的效率較差。為了測試這些in vitro實驗結果,我們選殖CRF07_BC molecular clone製造出野生型或帶有p6插入性突變之突變型CRF07_BC亞型病毒,發現將p6基因片段補回pCRF07_BC質體後,蛋白酶切割Gag polyprotein的效率上升,且病毒顆粒釋放的比率增加,顯示p6刪除性突變是造成CRF07_BC重組亞型病毒蛋白酶切割Gag polyprotein效率較差的原因。
zh_TW
dc.description.abstractHIV disease is a culmination of a complex interplay between both viral and host factors. Understanding the virologic characteristics of long-term non-progressers will help to develop strategies to prevent HIV infection and clinical treatment. Before 2004, sexual transmission is responsible for most HIV-1 infections in Taiwan. HIV-1 subtype B and CRF01_AE are the two predominant virus strains: subtype B accounts for about 70% of HIV infections and is responsible for a relative high proportion of infections among homosexual men; CRF01_AE accounts for 25% of HIV infections and is associated with heterosexual transmission. However, CRF07_BC was responsible for the outbreak of HIV-1 among intravenous drug users between 2004 and 2005 in Taiwan. According to clinicians’ observations, we found that, before highly active antiretroviral therapy, these CRF07_BC infected individuals tend to have lower viral loads and higher CD4 counts than those patients recently infected subtype B viruses. Therefore, the specific aim of this study is to determine the functional characteristics of HIV-1 CRF07_BC.
The full-length genomes of CRF07_BC infectious molecular clone was sequenced, analyzed. Compared to LTR of HXB2, two single base deletions are amongst the NF-KB ⅰand SP-1 I binding sites, respectively. Interestingly, compared to the subtype B’s (HXB2) LTR, there is a potential third NF-KB binding site in the subtype CRF07_BC’s LTR region due to the 4 base insertions and two base substitutions at nt 340–349. In addition to, we founded HIV CRF07_BC have 7-amino-acids-deletion mutation in both p6gag and p6pol proteins, one-amino-acid insertion mutation at position 140 residue in Vif protein, A89T mutation in Vpr NLS motif and G3A mutation in Nef myristoylation functional domain.
Viral RNA was extracted from thirty-two patients’ plasma, and the viral nucleotide sequences of the pol region were determined using reverse transcription and nested polymerase chain reaction (PCR). Deletion of 7 amino acids in both p6gag and p6pol proteins were also noted among the Taiwanese CRF07_BC strains (32/32, 100%). The cell lysates of infected cells were used for Western blotting analysis to determine the efficiency of Gag-Pol polyprotein processing. Our results showed that CRF07_BC harbor lower Gag polyprotein processing efficiency than subtype B. CRF07_BC full-length molecular clone was constructed to confirm this finding. Site-directed mutagenesis was performed to address the effects of deletion in p6 on Gag cleavage efficiency. Our results demonstrate that 7-amino-acids-deletion in p6 can affect virus release by impairing Gag cleavage efficiency.
en
dc.description.provenanceMade available in DSpace on 2021-06-16T22:56:59Z (GMT). No. of bitstreams: 1
ntu-101-R99424008-1.pdf: 5576627 bytes, checksum: 671452185d2d3c96da02c0a247e859fc (MD5)
Previous issue date: 2012
en
dc.description.tableofcontents目錄
致謝 ii
中文摘要 iii
英文摘要 v
圖目錄 x
表目錄 xii
第一章 緒論 1
1-1. 人類免疫缺乏病毒(HIV-1)與後天免疫缺乏症候群(AIDS) 1
1-2. HIV-1流行現況 1
1-3. HIV-1亞型 2
1-4. CRF07_BC重組亞型病毒 2
1-5. 病毒構造簡介 3
1-6. 基因功能 3
1-7. HIV replication 7
1-8. 病毒成熟化(Virion maturation) 8
1-9. HIV/AIDS疾病進程 9
1-9.1. 病毒因子 10
1-9.2. 宿主因子 12
1-10. 研究目的 13
第二章 實驗材料與方法 14
2-1. 實驗材料 14
2-2. 實驗方法 15
2-2.1 293T 細胞株培養 15
2-2.2 人類周邊血單核細胞 (PBMC)分離與培養 15
2-2.3 HIV病毒感染 16
2-2.4 萃取病毒懸浮液中的病毒RNA 16
2-2.5 病毒RNA反轉錄反應 17
2-2.6 即時定量聚合酶連鎖反應 17
2-2.7 萃取PBMC中的genomic DNA 18
2-2.8 5’-LTR聚合酶連鎖反應 19
2-2.9 gag-pol-env-nef-U3R聚合酶連鎖反應 20
2-2.10 製備結晶紫(crystal violet)洋菜膠 20
2-2.11 純化PCR片段 21
2-2.12 將dATP接到純化後之PCR片段上(A-tailing) 22
2-2.13 利用聚合酶連鎖反應方法製造插入性突變 22
2-2.14 轉型作用(Transformation) 23
2-2.15 以轉染實驗製造HIV病毒 23
2-2.16 蔗糖溶液超高速離心 24
2-2.17 蛋白質電泳 24
2-2.18 西方墨點轉漬法 24
2-2.19 統計方法與分析軟體 25
第三章 結果 26
3-1. 全長病毒基因體序列分析 26
3-1.1. LTR 26
3-1.2. 基質蛋白質(Matrix ; MA ; p17) 27
3-1.3. 衣殼蛋白質(Capsid ; CA ; p24) 28
3-1.4. 核蛋白質殼(Nucleocapsid ; NC ; p7) 28
3-1.5. p6gag及p6pol 28
3-1.6. 蛋白酶(Protease;PR) 29
3-1.7. 反轉錄酶(Reverse transcriptase;RT) 29
3-1.8. 嵌入酶(Integrase;IN) 29
3-1.9. RNA水解酶(RNaseH) 30
3-1.10. Gp41 30
3-1.11. Vif 30
3-1.12. Vpr 31
3-1.13. Vpu 31
3-1.14. Tat 31
3-1.15. Rev 32
3-1.16. Nef 32
3-2. CRF07_BC之p6gag及p6pol蛋白質發生7個胺基酸刪除性突變 32
3-3. CRF07_BC臨床病毒株之蛋白酶切割效率 33
3-4. 構築CRF07_BC病毒株全長基因體 molecular clone 33
3-5. CRF07_BC 病毒株全長基因體molecular clone亞型鑑定 34
3-6. CRF07_BC病毒株全長基因體 molecular clone可製造HIV病毒 35
3-7. CRF07_BC 病毒株全長基因體 molecular clone具感染能力 35
3-8. CRF07_BC亞型之蛋白酶切割效率較HXB2亞型為差 36
3-9. 利用聚合酶連鎖反應方法製造pCRF07_BC p6插入性突變 36
3-10. p6刪除性突變對於CRF07_BC亞型病毒組裝及切割的影響 36
3-11. p6刪除性突變對於CRF07_BC亞型病毒生長複製能力的影響 37
第四章 實驗討論 38
第五章 參考文獻 43
dc.language.isozh-TW
dc.subjectCRF07_BC亞型病毒zh_TW
dc.subject蛋白&#37238zh_TW
dc.subjectp6zh_TW
dc.subjectCRF07_BCen
dc.subjectproteaseen
dc.subjectp6en
dc.title人類免疫缺乏病毒CRF07_BC重組亞型病毒株之功能性探討zh_TW
dc.titleFunctional Characterization of HIV-1 CRF07_BC Strainen
dc.typeThesis
dc.date.schoolyear100-2
dc.description.degree碩士
dc.contributor.oralexamcommittee高全良,李君男,王錦?
dc.subject.keywordCRF07_BC亞型病毒,蛋白&#37238,p6,zh_TW
dc.subject.keywordCRF07_BC,protease,p6,en
dc.relation.page117
dc.rights.note有償授權
dc.date.accepted2012-08-10
dc.contributor.author-college醫學院zh_TW
dc.contributor.author-dept醫學檢驗暨生物技術學研究所zh_TW
Appears in Collections:醫學檢驗暨生物技術學系

Files in This Item:
File SizeFormat 
ntu-101-1.pdf
  Restricted Access
5.45 MBAdobe PDF
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

社群連結
聯絡資訊
10617臺北市大安區羅斯福路四段1號
No.1 Sec.4, Roosevelt Rd., Taipei, Taiwan, R.O.C. 106
Tel: (02)33662353
Email: ntuetds@ntu.edu.tw
意見箱
相關連結
館藏目錄
國內圖書館整合查詢 MetaCat
臺大學術典藏 NTU Scholars
臺大圖書館數位典藏館
本站聲明
© NTU Library All Rights Reserved